HIV, HCV and SARS-CoV-2: friends or foes? A case report

Data about co-infection of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), HIV, and hepatitis C virus (HCV) are still scarce. We describe a patient hospitalized for sore throat, fatigue, and myalgia with a personal history of HIV and occult HBV infection. His antiretroviral therapy included bictegravir/emtricitabine/tenofovir alafenamide. The nasopharyngeal swab was positive for SARS-CoV-2 and laboratory testing showed acute HCV. Antiretroviral therapy was continued, but no specific therapy for SARS-CoV-2 was started. After 4 weeks, the nasopharyngeal swab resulted negative for SARS-CoV-2 and biochemical tests revealed undetectable HCV RNA with normalization of transaminases. To the best of our knowledge, this is the first reported case of acute HCV in a patient with HIV and SARS-CoV-2 co-infection..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Italian Journal of Medicine - 15(2021), 3

Sprache:

Englisch

Beteiligte Personen:

Elena Garlatti Costa [VerfasserIn]
Cesare Mazzaro [VerfasserIn]
Alessandro Grembiale [VerfasserIn]
Alessandro Berto [VerfasserIn]
Rita De Rosa [VerfasserIn]
Silvia Grazioli [VerfasserIn]
Maurizio Tonizzo [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.italjmed.org [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Co-infection
HCV
HIV
Italy.
Medicine
R
SARS-CoV-2

doi:

10.4081/itjm.2021.1350

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ01846548X